?' The Yale Centerfor Clinical Investigation (YCCI) was createdto provide a """"""""home""""""""for training the next generation of clinical investigators. Key programmatic goals are to 1) attract highjy talented students and junior faculty acrossmedicine, nursing, public health, biological sciences and biomedical engineering;and train them in the use of state-of-the-art research tools;give them the skills to work within complex research teams;andsupport their professional development;and 2) foster the translation of disease-related discoveries from the laboratory into the community by: stimulating the creation of Interdisciplinary teams; making available state-of-the-art corefacilities andexpanded biostatistical and bioinformatics resources; establishing organizational and regulatory infrastructure for clinical studies;and forging a dynamicnew partnership that will integrate community leaders, physicians, and health centers. Participating institutions include the Schools of Medicine, Nursing, Public Health, the Department of Biomedical Engineering and Graduate Programs in Biological and Biomedical Sciences. The Investigative Medicine program (IMP) is central to YCCI'seducation and training efforts. It is a unique doctoral program that offers Ph.D. degreesin Health Sciences Research to highly qualified M.D. fellows embarking on careers in translational or clinical research. IMPwill be expanded with CTSA support to include nursing, public health, biological sciences, and MD-PhD students. YCCI has also created a Society of YCCI Faculty Mentors who will participate actively in the training and nurturing of the students andjunior faculty members identified as YCCI Clinical Scholars. Pilot andfeasibility (P&F) grants will be awardedfor. 1)junior faculty;2) interdisciplinary translational teams;3) newtechnologies;and4) community-based projects. YCCIwill cluster research cores around commonthemes,including: imaging;specimen analysis;physiology;cognition and behavior; drug development;and cell therapy. A newOffice of ResearchServices will provide facilities for """"""""one-stop"""""""" shopping for regulatory, biostatistical, bioinformatics, recruitment and other support services. YCCI will have an office to coordinate the University's effortsto address health issues facing our community. The University's decision to immediately provide substantial support to establish the YCCI reflects itsstrong commitment to an innovative redesign of our clinical and translational research activities.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
3UL1RR024139-04S3
Application #
7881109
Study Section
Special Emphasis Panel (ZRR1-CR-3 (01))
Program Officer
Merchant, Carol
Project Start
2009-09-25
Project End
2012-09-24
Budget Start
2009-09-25
Budget End
2012-09-24
Support Year
4
Fiscal Year
2009
Total Cost
$290,304
Indirect Cost
Name
Yale University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Kleinberger, Jeffrey W; Copeland, Kenneth C; Gandica, Rachelle G et al. (2018) Monogenic diabetes in overweight and obese youth diagnosed with type 2 diabetes: the TODAY clinical trial. Genet Med 20:583-590
Sheikh, Abdul Q; Saddouk, Fatima Zahra; Ntokou, Aglaia et al. (2018) Cell Autonomous and Non-cell Autonomous Regulation of SMC Progenitors in Pulmonary Hypertension. Cell Rep 23:1152-1165
Berkowitz, Robert I; Marcus, Marsha D; Anderson, Barbara J et al. (2018) Adherence to a lifestyle program for youth with type 2 diabetes and its association with treatment outcome in the TODAY clinical trial. Pediatr Diabetes 19:191-198
D'Souza, Deepak Cyril; Carson, Richard E; Driesen, Naomi et al. (2018) Dose-Related Target Occupancy and Effects on Circuitry, Behavior, and Neuroplasticity of the Glycine Transporter-1 Inhibitor PF-03463275 in Healthy and Schizophrenia Subjects. Biol Psychiatry 84:413-421
Kriska, Andrea; El Ghormli, Laure; Copeland, Kenneth C et al. (2018) Impact of lifestyle behavior change on glycemic control in youth with type 2 diabetes. Pediatr Diabetes 19:36-44
Tricò, Domenico; Natali, Andrea; Mari, Andrea et al. (2018) Triglyceride-rich very low-density lipoproteins (VLDL) are independently associated with insulin secretion in a multiethnic cohort of adolescents. Diabetes Obes Metab 20:2905-2910
Askie, Lisa M; Darlow, Brian A; Finer, Neil et al. (2018) Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration. JAMA 319:2190-2201
Wang, Quan; Campbell, Daniel J; Macari, Suzanne L et al. (2018) Operationalizing atypical gaze in toddlers with autism spectrum disorders: a cohesion-based approach. Mol Autism 9:25
Manfredo Vieira, S; Hiltensperger, M; Kumar, V et al. (2018) Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science 359:1156-1161
Politte, Laura C; Scahill, Lawrence; Figueroa, Janet et al. (2018) A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures. Neuropsychopharmacology 43:1772-1778

Showing the most recent 10 out of 964 publications